OTHER INFORMATION.
−Removed: the quarter ended September 30, 2024, no director or officer of the Company adopted or terminated any “Rule 10b5-1 trading arrangement”
+Added: Trading Arrangements and Policies
+Added: the quarter ended March 31, 2025, no director or officer of the Company adopted or terminated any “Rule 10b5-1 trading arrangement”
or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
−Removed: Certificate of Amendment to the Certificate of Incorporation of Neuraxis, Inc., dated August 22, 2024
−Removed: Certificate of Designation of Series B Preferred Stock, dated August 22, 2024
−Removed: Form of Unrestricted Stock Award Agreement by and between Neuraxis, Inc.
−Removed: and Grantees dated on July 1, 2024 (incorporated by reference to exhibit 10.1 to current report on Form 8-K, furnished to the SEC on July 5, 2024)
−Removed: Fourth Amendment to Securities Purchase Agreement, dated October 12, 2024, between the Company and Flagstaff International, LLC (incorporated by reference to exhibit 10.1 to current report on Form 8-K, furnished to the SEC on October 18, 2024)
−Removed: Form of Securities Purchase Agreement (incorporated by reference to exhibit 10.2 to current report on Form 8-K, furnished to the SEC on October 18, 2024)
−Removed: Form of Registration Rights Agreement (incorporated by reference to exhibit 10.2 to current report on Form 8-K, furnished to the SEC on October 18, 2024)
Certification pursuant to 18 U.S.C.
17 unchanged sentences
the undersigned, thereunto duly authorized.
−Removed: November 12, 2024
Brian Carrico
1 unchanged sentence
Executive Officer)
−Removed: November 12, 2024
Timothy Henrichs
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.